高原病

Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 4: environmental hazards & risks - high elevation travel & altitude illness. May 2023 [internet publication].全文

Roach RC, Hackett PH, Oelz O, et al. The 2018 lake louise acute mountain sickness score. High Alt Med Biol. 2018 Mar;19(1):4-6.全文  摘要

Luks AM, Auerbach PS, Freer L, et al. Wilderness medical society clinical practice guidelines for the prevention and treatment of acute altitude illness: 2019 update. Wilderness Environ Med. 2019 Dec;30(4s):S3-18.全文  摘要

Donegani E, Paal P, Küpper T, et al. Drug use and misuse in the mountains: a UIAA MedCom consensus guide for medical professionals. High Alt Med Biol. 2016 Sep;17(3):157-84. 摘要

Ritchie ND, Baggott AV, Andrew Todd WT. Acetazolamide for the prevention of acute mountain sickness - a systematic review and meta-analysis. J Travel Med. 2012 Sep-Oct;19(5):298-307.全文  摘要

1. Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 4: environmental hazards & risks - high elevation travel & altitude illness. May 2023 [internet publication].全文

2. Roach RC, Hackett PH, Oelz O, et al. The 2018 lake louise acute mountain sickness score. High Alt Med Biol. 2018 Mar;19(1):4-6.全文  摘要

3. Wright AD, Brearley SP, Imray CH. High hopes at high altitudes: pharmacotherapy for acute mountain sickness and high altitude cerebral and pulmonary oedema. Expert Opin Pharmacother. 2008 Jan;9(1):119-27. 摘要

4. Hultgren H. High altitude medicine. Stamford, CT: Hultgren Publications; 2001.

5. Honigman B, Theis MK, Koziol-McLain J, et al. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med. 1993 Apr 15;118(8):587-92. 摘要

6. Luks AM, Hackett PH. Medical conditions and high-altitude travel. N Engl J Med. 2022 Jan 27;386(4):364-73. 摘要

7. Hackett PH, Roach RC. High altitude illness. New Engl J Med. 2001 Jul 12;345(2):107-14. 摘要

8. Maggiorini M, Bärtsch P, Walter M, et al. Prevalence of acute mountain sickness in the Swiss Alps. BMJ. 1990 Oct 13;301(6756):853-5.全文  摘要

9. Vardy J, Vardy J, Judge K, et al. Acute mountain sickness and ascent rate in trekkers above 2500m in the Nepali Himalaya. Aviat Space Environ Med. 2006 Jul;77(7):742-4. 摘要

10. Murdoch DR. Altitude illness among tourists flying to 3740 meters elevation in the Nepal Himalayas. J Trav Med. 1995 Dec 1;2(4):255-256. 摘要

11. Purkayastha SS, Ray US, Arora BS, et al. Acclimatization at high altitude in gradual and acute induction. J Appl Physiol. 1995 Aug;79(2):487-92. 摘要

12. Basnyat B, Subedi D, Sleggs J, et al. Disoriented and ataxic pilgrims: an epidemiological study of acute mountain sickness and high altitude cerebral edema at a sacred lake at 4300m in the Nepal Himalayas. Wilderness Environ Med. 2000 Summer;11(2):89-93. 摘要

13. Gabry AL, Ledoux X, Mozziconacci M, et al. High altitude pulmonary edema at moderate altitude (<2,400m; 7,870 feet): a series of 52 patients. Chest. 2003 Jan;123(1):49-53. 摘要

14. Hackett PH, Roach RC. High altitude cerebral oedema. High Alt Med Biol. 2004 Summer;5(2):136-46. 摘要

15. Wilson MH, Newman S, Imray CH. The cerebral effects of ascent to high altitudes. Lancet Neurol. 2009 Feb;8(2):175-91. 摘要

16. Sanchez del Rio M, Moskowitz MA. High altitude headache: lessons from headaches at sea level. Adv Exp Med Biol. 1999;474:145-53. 摘要

17. Bärtsch P, Bailey DM, Berger MM, Knauth M, et al. Acute mountain sickness: controversies and advances. High Alt Med Biol. 2004 Summer;5(2):110-24. 摘要

18. Bärtsch P, Roach RC. Acute mountain sickness. In: Hornbein TF, Schoene RB, eds. High altitude: an exploration of human adaptation, vol 161. New York: Marcel Dekker; 2001:731-776.

19. Jensen JB, Wright AD, Lassen NA, et al. Cerebral blood flow in acute mountain sickness. J Appl Physiol. 1990 Aug;69(2):430-3. 摘要

20. Schoene RB. Unraveling the mechanism of high altitude pulmonary edema. High Alt Med Biol. 2004 Summer;5(2):125-35. 摘要

21. Maggiorini M. High altitude-induced pulmonary edema. Cardiovasc Res. 2006 Oct 1;72(1):41-50. 摘要

22. Dehnert C, Risse F, Ley S, et al. Magnetic resonance imaging of uneven pulmonary perfusion in hypoxia in humans. Am J Resp Crit Care Med. 2006 Nov 15;174(10):1132-8. 摘要

23. Hackett PH, Yarnell PR, Hill R, et al. High altitude cerebral edema evaluated with magnetic resonance imaging. JAMA. 1998 Dec 9;280(22):1920-5. 摘要

24. Sartori C, Lepori M, Maggiorini M, et al. Impairment of amiloride-sensitive sodium transport in individuals susceptible to HAPE. In: Roach RC, Wagner P, Hackett PH, eds. Hypoxia into the next millennium. New York: Kluwer Academic/Plenum; 1999:426.

25. Sartori C, Allemann Y, Duplain H, et al. Salmeterol for the prevention of high altitude pulmonary edema. New Engl J Med. 2002 May 23;346(21):1631-6. 摘要

26. Hackett PH, Rennie D. The incidence, importance and prophylaxis of acute mountain sickness. Lancet. 1976 Nov 27;2(7996):1149-55. 摘要

27. Singh I, Kapila C, Khanna P, et al. High altitude pulmonary edema. Lancet. 1965 Jan 30;1(7379):229-34. 摘要

28. Burtscher M, Brandstätter E, Gatterer H. Preacclimatization in simulated altitudes. Sleep Breath. 2008 May;12(2):109-14. 摘要

29. Luks AM, Auerbach PS, Freer L, et al. Wilderness medical society clinical practice guidelines for the prevention and treatment of acute altitude illness: 2019 update. Wilderness Environ Med. 2019 Dec;30(4s):S3-18.全文  摘要

30. Richalet J-P, Keromes A, Dersch B, et al. Caracteristiques physiologiques des alpinistes de haute altitude. Sci Sports. 1988;3:89-108.

31. Schneider M, Bernasch D, Weymann J, et al. Acute mountain sickness: influence of susceptibility, pre-exposure and ascent rate. Med Sci Sports Exerc. 2002 Dec;34(12):1886-91. 摘要

32. Ziaee V, Yunesian M, Ahmadinejad Z, et al. Acute mountain sickness in Iranian trekkers around Mt Damavand in Iran. Wilderness Environ Med. 2003 Winter;14(4):214-9. 摘要

33. Graham J, Potyk D. Age and acute mountain sickness - examining the data. JAGS. 2005 Apr;53(4):735. 摘要

34. Vearrier D, Greenberg MI. Occupational health of miners at altitude: adverse health effects, toxic exposures, pre-placement screening, acclimatization, and worker surveillance. Clin Toxicol (PA). 2011 Aug;49(7):629-40. 摘要

35. Roach RC, Maes D, Sandoval D, et al. Exercise exacerbates acute mountain sickness at simulated altitude. J Appl Physiol. 2000 Feb;88(2):581-5.全文  摘要

36. Gaillard S, Dellasanta P, Lautan L, et al. Awareness, prevalence, medication use and risk factors of acute mountain sickness in tourists trekking around the Annapurna in Nepal: a 12 year follow-up. High Alt Med Biol. 2004 Winter;5(4):410-9. 摘要

37. Basnyat B, Gertsch JH, Holck PS, et al. Acetazolamide 125mg BD is not significantly different from 37mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) TRIAL. High Alt Med Biol Spr. 2006 Spring;7(1):17-27. 摘要

38. Dumont L, Mardirosoff C, Tramèr MR. Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ. Jul 29;321(7256):267-72.全文  摘要

39. Williamson J, Oakeshott P, Dallimore J. Altitude sickness and acetazolamide. BMJ. 2018 May 31;361:k2153. 摘要

40. Donegani E, Paal P, Küpper T, et al. Drug use and misuse in the mountains: a UIAA MedCom consensus guide for medical professionals. High Alt Med Biol. 2016 Sep;17(3):157-84. 摘要

41. Nieto Estrada VH, Molano Franco D, Medina RD, et al. Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs. Cochrane Database Syst Rev. 2017 Jun 27;6:CD009761.全文  摘要

42. Gonzalez Garay A, Molano Franco D, Nieto Estrada VH, et al. Interventions for preventing high altitude illness: Part 2. Less commonly-used drugs. Cochrane Database Syst Rev. 2018 Mar 12;3:CD012983.全文  摘要

43. Molano Franco D, Nieto Estrada VH, Gonzalez Garay AG, et al. Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions. Cochrane Database Syst Rev. 2019 Apr 23;4:CD013315.全文  摘要

44. Tsai TY, Wang SH, Lee YK, et al. Ginkgo biloba extract for prevention of acute mountain sickness: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2018 Aug 17;8(8):e022005.全文  摘要

45. Bärtsch P, Maggiorini M, Ritter M, et al. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. 1991 Oct 31;325(18):1284-9.全文  摘要

46. Yaron M, Niermeyer S. Travel to high altitude with young children: an approach for clinicians. High Alt Med Biol. 2008 Winter;9(4):265-9.全文  摘要

47. Bailey DM, Kleger GR, Holzgraefe M, et al. Pathophysiological significance of peroxidative stress, neuronal damage, and membrane permeability in acute mountain sickness. J Appl Physiol (1985). 2004 Apr;96(4):1459-63.全文  摘要

48. Davis C, Hackett P. Advances in the prevention and treatment of high altitude illness. Emerg Med Clin North Am. 2017 May;35(2):241-60. 摘要

49. Maggiorini M, Bärtsch P, Oelz O. Association between raised body temperature and acute mountain sickness: cross sectional study. BMJ. 1997 Aug 16;315(7105):403-4. 摘要

50. Bärtsch P, Shaw S, Franciolli M, et al. Atrial natriuretic peptide in acute mountain sickness. J Appl Physiol. 1988 Nov;65(5):1929-37. 摘要

51. Bircher HP, Eichenberger U, Maggiorini M, et al. Relationship of mountain sickness to physical fitness and exercise intensity during ascent. J Wilderness Med. 1994;5:302-311.

52. Roach RC, Greene ER, Schoene RB, et al. Arterial oxygen saturation for prediction of acute mountain sickness. Aviat Space Environ Med. 1998 Dec;69(12):1182-5. 摘要

53. Schoene RB, Swenson ER, Hultgren HN. High altitude pulmonary edema. In: Hornbein TF, Schoene RB, eds. High altitude: an exploration of human adaptation. New York, NY: Marcel Dekker; 2001:777-814.

54. Menon ND. High altitude pulmonary edema: a clinical study. New Engl J Med. 1965 Jul 8;273:66-73. 摘要

55. Ward MP, Milledge JS, West JB. High altitude medicine and physiology. 3rd ed. London: Arnold; 2000.

56. Vock P, Fretz C, Franciolli M, et al. High altitude pulmonary edema; findings at high altitude chest radiography and physical examination. Radiology. 1989 Mar;170(3 Pt 1):661-6. 摘要

57. Fagenholz PJ, Gutman JA, Murray AF, et al. Treatment of high altitude pulmonary edema at 4240 m in Nepal. High Alt Med Biol. 2007 Summer;8(2):139-46. 摘要

58. Marticorena E, Tapia FA, Dyer J, et al. Pulmonary edema by ascending to high altitudes. Dis Chest. 1964 Mar;45:273-83. 摘要

59. Houston CS. Acute pulmonary edema of high altitude. New Engl J Med. 1960 Sep 8;263:478-80. 摘要

60. Fagenholz PJ, Gutman JA, Murray AF, et al. Chest ultrasonography for the diagnosis and monitoring of high altitude pulmonary edema. Chest. 2007 Apr;131(4):1013-8. 摘要

61. Allemann Y, Hutter D, Lipp E, et al. Patent foramen ovale and high altitude pulmonary edema. JAMA. 2006 Dec 27;296(24):2954-8.全文  摘要

62. Houston CS, Dickinson J. Cerebral form of high altitude illness. Lancet. 1975 Oct 18;2(7938):758-61. 摘要

63. Windsor JS, Rodway GW. Supplemental oxygen and sleep at high altitude. High Alt Med Biol. 2006 Winter;7(4):307-11. 摘要

64. Hultgren H, Honigman B, Theis K, et al. High altitude pulmonary edema in a ski resort. West J Med. 1996 Mar;164(3):222-7. 摘要

65. Cogo A, Fischer R, Schoene R. Respiratory disease and high altitude. High Alt Med Biol. 2004 Winter;5(4):435-44. 摘要

66. Faulhaber M, Flatz M, Gatterer, et al. Prevalence of cardiovascular diseases among alpine skiers and hikers in the Austrian Alps. High Alt Med Biol. 2007 Fall;8(3):245-52. 摘要

67. Lipman GS. Carbon monoxide toxicity at high altitude. Wilderness Environ Med. 2006 Summer;17(2):144-5. 摘要

68. Ahmad H. Diabetic ketoacidosis in an undiagnosed diabetic precipitated by high altitude pulmonary edema. High Alt Med Biol. 2006 Spring;7(1):84-6. 摘要

69. Speedy DB, Noakes TD, Rogers IR, et al. Hyponatraemia in ultradistance triathletes. Med Sci Sports Exerc. 1999 Jun;31(6):809-15. 摘要

70. Schmidt W, Rojas J, Boning D, et al. Plasma electrolytes in natives to hypoxia after marathon races at different altitudes. Med Sci Sports Exerc. 1999 Oct;31(10):1406-13. 摘要

71. Baumgartner RW, Siegel AM, Hackett PH. Going high with preexisting neurological conditions. High Alt Med Biol. 2007 Summer;8(2):108-16. 摘要

72. Sampson JB, Cymerman A, Burse RL, et al. Procedures for the measurement of acute mountain sickness. Aviat Space Environ Med. 1983 Dec;54(12 pt 1):1063-73. 摘要

73. Barry PW, Pollard AJ. Altitude illness. BMJ. 2003 Apr 26;326(7395):915-9.全文  摘要

74. Rock PB, Johnson TS, Larsen RF, et al. Dexamethasone as prophylaxis for acute mountain sickness. Effects of dose level. Chest. 1989 Mar;95(3):568-73. 摘要

75. Subedi BH, Pokharel J, Goodman TL, et al. Complications of steroid use on Mt. Everest. Wilderness Environ Med. 2010 Dec;21(4):345-8. 摘要

76. Low EV, Avery AJ, Gupta V, et al. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis. 2012 Oct 18;345:e6779.全文  摘要

77. Ritchie ND, Baggott AV, Andrew Todd WT. Acetazolamide for the prevention of acute mountain sickness - a systematic review and meta-analysis. J Travel Med. 2012 Sep-Oct;19(5):298-307.全文  摘要

78. Seupaul RA, Welch JL, Malka ST, et al. Pharmacologic prophylaxis for acute mountain sickness: a systematic shortcut review. Ann Emerg Med. 2012 Apr;59(4):307-317. 摘要

79. Ferrazzini G, Maggiorini M, Kriemler S, et al. Successful treatment of acute mountain sickness with dexamethasone. BMJ. 1987 May 30;294(6584):1380-2.全文  摘要

80. Wu TY, Ding SQ, Liu JL, et al. High-altitude gastrointestinal bleeding: an observation in Qinghai-Tibetan railroad construction workers on Mountain Tanggula. World J Gastroenterol. 2007 Feb 7;13(5):774-80. 摘要

81. Burtscher M, Likar R, Nachbauer W, et al. Aspirin for prophylaxis against headache at high altitudes: randomized, double blind, placebo controlled trial. BMJ. 1998 Apr 4;316(7137):1057-8.全文  摘要

82. Simancas-Racines D, Arevalo-Rodriguez I, Osorio D, et al. Interventions for treating acute high altitude illness. Cochrane Database Syst Rev. 2018 Jun 30;6:CD009567.全文  摘要

83. Grissom CK, Roach RC, Samquist FH, et al. Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann Intern Med. 1992 Mar 15;116(6):461-5. 摘要

84. Wright AD, Winterborn MH, Forster PJ, et al. Carbonic anhydrase inhibition in the immediate therapy of acute mountain sickness. J Wilderness Med. 1994;5:49-55.

85. Nerin MA, Palop J, Montano JA, et al. Acute mountain sickness: influence of fluid intake. Wilderness Environ Med. 2006 Winter;17(4):215-20. 摘要

86. Keller HR, Maggiorini M, Bärtsch P, et al. Simulated descent vs dexamethasone in treatment of AMS - a randomized trial. BMJ. 1995 May 13;310(6989):1232-5.全文  摘要

87. Irons HR, Salas RN, Bhai SF, et al. Prospective double-blinded randomized field-based clinical trial of metoclopramide and ibuprofen for the treatment of high altitude headache and acute mountain sickness. Wilderness Environ Med. 2020 Mar;31(1):38-43.全文  摘要

88. European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide​. Jul 2013 [internet publication].全文

89. Weil JV. Sleep at altitude. High Alt Med Biol. 2004 Summer;5(2):180-9. 摘要

90. Beaumont M, Goldenberg F, Lejeune D, et al. Effect of zolpidem on sleep an ventilatory patterns at simulated altitude of 4000m. Am J Crit Care Med. 1996 Jun;153(6 Pt 1):1864-9. 摘要

91. Dubowitz G. Effect of temazepam on oxygen saturation and sleep quality at high altitude: randomized placebo controlled crossover trial. BMJ. 1998 Feb 21;316(7131):587-9.全文  摘要

92. Rodway GW, Windsor JS, Hart ND, Caudwell Xtreme Everest Research Group. Supplemental oxygen and hyperbaric treatment at high altitude: cardiac and respiratory response. Aviat Space Environ Med. 2007 Jun;78(6):613-7. 摘要

93. Oelz O, Maggiorini M, Ritter M, et al. Nifedipine for high altitude pulmonary edema. Lancet. 1989 Nov 25;2(8674):1241-4. 摘要

94. Ghofrani HA, Reichenberger F, Kohstall MG. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med. 2004 Aug 3;141(3):169-77. 摘要

95. Richalet JP, Gratadour P, Robach P, et al. Sildenafil inhibits altitude-induced hypoxia and pulmonary hypertension. Am J Resp Crit Care. 2005 Feb 1;171(3):275-81.全文  摘要

96. Maggiorini M, Brunner-La Rocca HP, Peth S, et al. Both tadalafil and dexamethasone may reduce the incidence of high altitude pulmonary edema. Ann Int Med. 2006 Oct 3;145(7):497-506. 摘要

97. van Patot MC, Keyes LE, Leadbetter G 3rd, et al. Ginkgo biloba for prevention of acute mountain sickness: does it work? High Alt Med Biol. 2009 Spring;10(1):33-43. 摘要